Sabatolimab (MBG453) Combination Treatment Regimens for Patients With Higher-Risk Myelodysplastic Syndromes (HR-MDS): The Myelodysplastic Syndromes Studies in the STIMULUS Immuno-Myeloid Clinical Trial Program

被引:0
作者
Zeidan, Amer M. [1 ,2 ]
Al-Kali, Aref [3 ]
Borate, Uma [4 ]
Cluzeau, Thomas [5 ]
DeZern, Amy E. [6 ]
Esteve, Jordi [7 ]
Giagounidis, Aristoteles [8 ]
Kobata, Krissy [9 ]
Lyons, Roger [10 ]
Platzbecker, Uwe [11 ]
Sallman, David A. [12 ]
Santini, Valeria [13 ]
Sanz, Guillermo F. [14 ,15 ]
Sekeres, Mikkael A. [16 ]
Wei, Andrew H. [17 ,18 ]
Xiao, Zhijian [19 ]
Van Hoef, Marlies [20 ]
Nourry-Boulot, Claire [20 ]
Sadek, Islam [21 ]
Ma, Fei [21 ]
Iordan, Angelica [20 ]
Sabo, John [21 ]
Garcia-Manero, Guillermo [22 ]
机构
[1] Yale Univ, New Haven, CT USA
[2] Yale Canc Ctr, New Haven, CT USA
[3] Mayo Clin, Rochester, MN USA
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[5] Ctr Hosp Univ Nice, Nice, France
[6] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[7] Hosp Clin Barcelona, Barcelona, Spain
[8] Marien Hosp, Dusseldorf, Germany
[9] Patient, Los Angeles, CA USA
[10] US Oncol Network, San Antonio, TX USA
[11] Univ Hosp Leipzig, Leipzig, Germany
[12] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[13] Univ Florence, Florence, Italy
[14] Inst Salud Carlos III, Hosp Univ & Politecn La Fe, Madrid, Spain
[15] Inst Salud Carlos III, CIBERONC, Madrid, Spain
[16] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[17] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic, Australia
[18] Royal Melbourne Hosp, Melbourne, Vic, Australia
[19] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
[20] Novartis Pharma AG, Basel, Switzerland
[21] Novartis Pharmaceut, E Hanover, NJ USA
[22] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
MDS; myelodysplastic syndrome; clinical trial; azacitidine; venetoclax; Trial-in-Progress;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MDS-476
引用
收藏
页码:S317 / S317
页数:1
相关论文
empty
未找到相关数据